NBY vs TRV · $51.9M cap vs P/E 14, rev $12.15B
NovaBay Pharmaceuticals Inc (NBY) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
NBY does not have a complete income-statement cache yet.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
NBY currently screens at market cap $51.9M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the NBY and TRV stock pages for the full models.
Not investment advice.